U.S. markets closed
  • S&P 500

    4,247.44
    +8.26 (+0.19%)
     
  • Dow 30

    34,479.60
    +13.36 (+0.04%)
     
  • Nasdaq

    14,069.42
    +49.09 (+0.35%)
     
  • Russell 2000

    2,335.81
    +24.40 (+1.06%)
     
  • Crude Oil

    70.78
    +0.49 (+0.70%)
     
  • Gold

    1,879.50
    -16.90 (-0.89%)
     
  • Silver

    28.05
    +0.02 (+0.07%)
     
  • EUR/USD

    1.2107
    -0.0071 (-0.58%)
     
  • 10-Yr Bond

    1.4620
    +0.0030 (+0.21%)
     
  • GBP/USD

    1.4117
    -0.0060 (-0.42%)
     
  • USD/JPY

    109.6350
    +0.2870 (+0.26%)
     
  • BTC-USD

    35,833.27
    -1,022.48 (-2.77%)
     
  • CMC Crypto 200

    924.19
    -17.62 (-1.87%)
     
  • FTSE 100

    7,134.06
    +45.88 (+0.65%)
     
  • Nikkei 225

    28,948.73
    -9.83 (-0.03%)
     

PRESS DIGEST- Wall Street Journal - June 11

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

June 11 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

- A prominent Harvard drug researcher on Thursday became the third member of a Food and Drug Administration advisory committee to resign over the agency's decision to approve Biogen Inc's drug for Alzheimer's, questioning whether the drug works. https://on.wsj.com/3pELMWQ

- The Biden administration launched an initiative Thursday aiming to make more government data available to artificial intelligence researchers, part of a broader push to keep the U.S. on the cutting edge of the crucial new technology. https://on.wsj.com/3gcQoQP

- The U.S. government has halted new shipments of the Johnson & Johnson COVID-19 vaccine, according to state and federal health officials, one of several steps federal agencies are taking that could help clear a backlog of unused doses before they expire. https://on.wsj.com/3wd9VpO

- Federal agencies will no longer be required to limit the number of employees in their workplaces but will maintain a telework policy established during the COVID-19 pandemic, the Biden administration said Thursday. https://on.wsj.com/3viiKxb

(Compiled by Bengaluru newsroom)